Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Size, Share & Trends Analysis Report By Type of Services (Development Services, Manufacturing Services, and Others (Regulatory expertise and support, Quality Control and Assurance)), By Scale of operations, By Application, By Region, And By Segment Forecasts, 2025-2034.
The Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Size is valued at 230.8 Million in 2024 and is predicted to reach 1,456.9 Million by the year 2034 at a 18.1% CAGR during the forecast period for 2025-2034 Key Industry Insights & Findings from the Report: Increasing R&D activities aimed at redefining the development of next-generation live biotherapeutic and microbiome contract manufac...
Report ID: 1152 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 190
Gene Therapy for Blood Disorders Market Size, Share & Trends Analysis Report By Indication (Sickle Cell Anemia, ?-thalassemia, Hemophilia B, Hemophilia A), By Mechanism of Action (Gene Therapy, Gene Editing), By Region, And Segment Forecasts, 2025-2034
Gene Therapy for Blood Disorders Market Size is estimated to grow at a 15.3% CAGR during the forecast period for 2025-2034. The Arena of Gene Therapy is determined to outline a path to the clinic and the market. In the gene therapy market, over 2000 human gene therapy clinical trials have been reported globally, and about 20 gene therapy products are approved to treat various disorders. Hence, the demand for gene therapy to treat blood disorde...
Report ID: 1156 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 185
Neuropsychiatric Drugs Market Size, Share & Trends Analysis Report By Drug Type (Typical Antipsychotics and Atypical Antipsychotics), By Indication, By Route Of Administration, Region And Segment Forecasts, 2025-2034.
Neuropsychiatric Drugs Market is expected to grow at a 5.0% CAGR during the forecast period for 2025-2034. Neuropsychiatric disorders are psychological disorder occur owing to a functional disturbance in the cerebral system. According to the National Institutes of Health, Neuropsychiatric disorders are one of the top 10 leading causes of global disability-adjusted life years (DALYs). The neuropsychiatry is concerned with illnesses of behavior ...
Report ID: 1170 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Beyond the Pill Market Size, Share & Trends Analysis Report By Therapeutic Area (Diabetes, Oncology, Cardiovascular Diseases, Asthma, And Others) And Offerings (Services, Monitoring, Assistance, Information, And Education), By Region, And Segment Forecasts, 2025-2034
Beyond The Pill Market Size is predicted to register at an 11.8% CAGR during the forecast period for 2025-2034 Key Industry Insights & Findings from the Report: The increasing elderly population, increased public understanding of healthcare, and changing lifestyles are all driving forces in the market growth. Rising technology advancements in healthcare and the shift to personalized medical care are expected to drive industry growth. ...
Report ID: 1567 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Smart Pharmaceutical Factory Technologies Market Size, Share & Trends Analysis Report by Product Type (Manufacturing Execution Systems, Automation Systems, Analytical & Monitoring Systems), By Technology Type (IoT, Artificial Intelligence & Machine Learning, Big Data Analytics, Robotics & Automation), By Application (Drug Discovery & Development, Manufacturing & Production, Quality Control & Compliance), By End User (Pharmaceutical & Biotech Companies, CMOs, Research Institutes & Academia), Region And Segment Forecasts, 2025-2034
Smart Pharmaceutical Factory Technologies Market Size is predicted to witness at a 20.3% CAGR during the forecast period for 2025-2034. Pharmaceutical production processes are being revolutionized by a variety of cutting-edge systems and solutions known as smart pharmaceutical factory technologies. Adopting smart pharmaceutical factory technology can increase productivity, improve quality control, increase safety, lower costs, and shorten the ...
Report ID: 1903 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Clinical Trial Planning and Design Services Market Size, Share & Trends Analysis Report By Trial Phase, By Therapeutic Area (Oncological Disorders, Cardiovascular Disorders, Inflammatory Disorders, Neurological Disorders, Other Therapeutic Areas), By Service, By Region, And by Segment Forecasts, 2025-2034
Clinical Trial Planning and Design Services Market Size is predicted to reach at an 9.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Due to advances in research and medical technology, clinical trials are becoming increasingly complex. This complexity requires specialized expertise in test planning and design to ensure efficiency and compliance with regulatory standards. The globaliz...
Report ID: 1452 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Microbial API Market Size, Share & Trends Analysis Report By Type (Antibiotics, Amino acids, Vitamins, Nucleotides, Organic Acids, Biological Products, Hormones), By Application (Hospitals, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies), By Region, And Segment Forecasts, 2025-2034
The Global Microbial API Market Size is predicted to witness at a 7.0% CAGR during the forecast period for 2025-2034. The term "Active Pharmaceutical Ingredients," or "API," refers to the components of a medicine that are essential for the drug's biological activity. Chemical synthesis, fermentation, recombinant DNA, isolation, and source recovery are common industrial processes. Fermentation is carried out by microorganisms, which also produc...
Report ID: 1716 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Radiopharmaceutical Preclinical CRO Market Size, Share & Trends Analysis Distribution by Organization Size (Small & Medium Enterprises (SMEs), Large Pharmaceutical Corporations), Radiopharmaceutical Types (PET Tracers, SPECT Tracers, Therapeutic Radiopharmaceuticals), Services, Therapeutic Area, End-Users and Segment Forecasts, 2025-2034
Global Radiopharmaceutical Preclinical CRO Market Size is predicted to witness an 8.5% CAGR during the forecast period for 2025-2034. The radiopharmaceutical preclinical CRO market is a vital part of the healthcare and pharmaceutical industry, dedicated to the development and testing of radiopharmaceutical drugs. This drug contains radioactive isotopes used for diagnostic imaging and therapeutic purposes. These CROs provide essential...
Report ID: 2712 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 170
Traditional Medicine Market Size, Share & Trends Analysis Report By Product (Herbal Medicine, Ayurvedic Medicine, Unani Medicine, Alternative Medicine, Homeopathy Medicine, Others ), By Form (Capsules and Tablets, Powders and Granules, Liquid Extracts, Syrups, Creams and Ointment, Others ), By Disease Indication (Cardiac Disorders, Bone and Joint Disorders, Gynecological Disorders, Neurological and Mental Disorders, Digestive Disorders, Others), By Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, Specialty Stores, Direct Sales, By Region, And By Segment Forecasts, 2025-2034
Global Traditional Medicine Market Size is valued at USD 190.95 Bn in 2024 and is predicted to reach USD 426.70 Bn by the year 2034 at a 8.5% CAGR during the forecast period for 2025-2034. Traditional medicine encompasses a variety of health practices, theories, and beliefs based on indigenous cultural backgrounds. It includes herbal remedies, acupuncture, dietary therapies, and physical exercises like yoga and Tai Chi, among others. Rooted in a...
Report ID: 2351 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Cell and Gene Therapy Manufacturing Quality Control (QC) Market Size, Share & Trends Analysis Report By Component (Equipment & Accessories, Consumables, Others), By Application (Sterility Testing, Purity Testing, Potency Testing, Identity Testing, Others (stability, viability, etc.)), By Process (Upstream Processing, Downstream Processing, Packaging), By End-User (Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations), By Region, And By Segment Forecasts, 2025-2034
Cell and Gene Therapy Manufacturing Quality Control (QC) Market Size is valued at USD 2.71 Bn in 2024 and is predicted to reach USD 16.32 Bn by the year 2034 at a 19.8% CAGR during the forecast period for 2025-2034. A crucial element in the production of cell and gene therapies, quality control (QC) guarantees the advanced therapeutic products' safety, potency, integrity, and efficacy prior to their administration to patients. Considering the ...
Report ID: 2395 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
Pharmaceuticals